| NOVARTIS NAM. ADR 1 |
| USA |
| Gesundheit |
| US66987V1098 / 907122 |
| NOTA (Frankfurt) / NVS (NYSE) |
| FRA:NOTA, ETR:NOTA, NOTA:GR, NYSE:NVS |
| - |
| https://www.novartis.com/ |
|
Novartis AG Sponsored ADR represents ownership in Novartis AG, a global healthcare company focused on researching, developing, manufacturing, and marketing innovative medicines. Through this ADR structure, U.S. investors can gain exposure to Novartis..
>Volltext.. |
| 241141.45 Mio. EUR |
| 276077.08 Mio. EUR |
| 47221.11 Mio. EUR |
| 18493.33 Mio. EUR |
| 11751.7 Mio. EUR |
| 6.1 EUR |
| 40605.03 Mio. EUR |
| 5941.55 Mio. EUR |
| 16664.01 Mio. EUR |
| 0.22 |
| 5.6% |
| 5.67% |
| 4.11 EUR |
| 2% |
| 2.65% |
| 11.03.26 - 4.1123834€ 12.03.25 - 3.4268434€ >weitere anzeigen... |
| - |
| NOVARTIS ADR, NOVARTIS |
| 13.06.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|